Süssmuth SD

Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.

1 paper

ArticlePsychedelics

Safety and Efficacy of the NMDA-2b-Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder.

McIntyre RS, Sanacora G, Walling DP +7